<DOC>
	<DOCNO>NCT02376049</DOCNO>
	<brief_summary>An Explorative Clinical Trial Evaluate Intra Patient Comparison Design Topical Agents Adults Mild Moderate Atopic Dermatitis .</brief_summary>
	<brief_title>A Clinical Trial Compare Topical Agents Adults With Mild Moderate Atopic Dermatitis ( AD )</brief_title>
	<detailed_description>Multi-center , prospective , randomize , vehicle-controlled , investigator-blinded , stable lesion design .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Subject mild moderate AD Four comparable TAs TSS least 5 TAs Difference TSS great 2 TAs Sign score erythema â‰¥ 2 TAs TAs least 2 cm apart Investigator 's opinion Fitzpatrick skin type &gt; 5 Topical ( i.e . TAs ) treatment prohibit medication Systemic treatment prohibit medication Phototherapy within prohibit timeframe Use emollient within prohibit timeframe</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Eczema</keyword>
	<keyword>AD</keyword>
</DOC>